search
Back to results

Caudal Dexmedetomidine Analgesia in Pediatrics .

Primary Purpose

164 Boys for Hypospadias Surgery Under General Anesthesia With Caudal Block

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Caudal dexamedatomidine analgesia
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for 164 Boys for Hypospadias Surgery Under General Anesthesia With Caudal Block focused on measuring Caudal, Dexmedetomidine, Levobupivacaine, hypospadias

Eligibility Criteria

1 Year - 8 Years (Child)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • 164 boys (age 1-8 years, ASA I) scheduled for hypospadias surgery

Exclusion Criteria:

  • Operative time exceeding 3 hours, bodyweight >25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study

Sites / Locations

  • Anesthesia department,Faculty of medicine, Mansoura univerisety

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

• Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/k

• Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.

• Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/

• Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.

Arm Description

Outcomes

Primary Outcome Measures

Time to (1st analgesic request objective pain score (OPS) ≥4)
time from full recovery till child express moderate pain OPS 4 and ask for the first analgesic dose

Secondary Outcome Measures

Full Information

First Posted
December 29, 2018
Last Updated
February 26, 2021
Sponsor
Mansoura University
search

1. Study Identification

Unique Protocol Identification Number
NCT03791879
Brief Title
Caudal Dexmedetomidine Analgesia in Pediatrics .
Official Title
The Analgesic Effectiveness and Safety of Upgraded Caudal Dexmedetomidine Doses in Pediatric Hypospadias Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
October 1, 2020 (Actual)
Study Completion Date
October 15, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study is designed to evaluate the analgesic effect of caudal increasing doses of DEXM 0.5 , 1 , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least effective concentration) in providing pain relief over a 24-h period and lowest surgical stress peak. Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different increasing doses of dexamedatomedine >1 µg/kg could not add more analgesic & stress response obtundation outcome, but increase side effects (sedation and hemodynamic depression). The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. Aim of the Study: To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated with the least side effects& stress response modulation, guided by PO Cortisol peak difference in between the study groups during pediatric hypospadias surgery.
Detailed Description
Background: Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study is designed to evaluate the analgesic effect of caudal increasing doses of DEXM 0.5 , 1 , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least effective concentration) in providing pain relief over a 24-h period and lowest surgical stress peak. Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different increasing doses of dexamedatomedine >1 µg/kg could not add more analgesic & stress response obtundation outcome, but increase side effects (sedation and hemodynamic depression).The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. Aim of the Study: To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated with the least side effects& stress response modulation, guided by PO Cortisol peak difference in between the study groups during pediatric hypospadias surgery. Optimal effective dose defined as; the least caudal DEXM dose which produce the best analgesic outcome [least time to 1st analgesic request and lowest rescue analgesic dose (24Hs)] associated with the least stress response (cortisol PO. first One hour peak), least PO sedation, and hemodynamic stability IO. &PO. HR & MAP. The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. . Material & Methods A prospective randomized double blinded (drug injector and PO assessor) comparative study will be conducted in Mansoura university hospital after obtaining ethics committee approval and written informed parental consent 164 boys (age 1-6 years, ASA I) scheduled for hypospadias surgery. Exclusion criteria; (Operative time exceeding 3 hours, bodyweight >25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study. Patients will fast for solids 6h and water and 2 hours before surgery. After Patient Preoperative preparation, General anesthesia induction, caudal block and caudal drug injection (Levob plus DEXM) bolus will be injected according to each group as follow; Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/kg. Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg. Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/kg. Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg. The study outcomes recording: 1ry outcome: Time to (1st analgesic request OPS >4). Secondary outcome: Total 24hours PO. Rescue analgesic dose IM pethidine 0.5mg/kg [2,3] based on local policy and protocol, Patients demographic data [age, weight, end tidal Sevoflurane (volume %) prior starting skin closure, intraoperative fentanyl total dose, recovery time (time from discontinuation of anesthesia to spontaneous eye opening)], Serum Cortisol level at basal before anesthesia and 1hour postoperative in between groups [1] , Apnea incidence (NO&%), and desaturation (NO&%), Objective pain score, Sedation score, Behavioral score for Agitation assessment, and Modified bromage score (residual Lower limb muscle weakness) recorded every 15 minutes for 1st hour then every 30 minutes for next 3 PO hours then at next 6th, 12th, 18th, 24th PO hours, hemodynamics, HR&SBP the incidence of bradycardia and hypotension per 50% percentile. Recorded every 10 minutes IO for maximum operative time 3 hours and every 30 min PO for next 2h in the recovery room until the child was discharged to the ward.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
164 Boys for Hypospadias Surgery Under General Anesthesia With Caudal Block
Keywords
Caudal, Dexmedetomidine, Levobupivacaine, hypospadias

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
164 (Actual)

8. Arms, Groups, and Interventions

Arm Title
• Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/k
Arm Type
Active Comparator
Arm Title
• Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.
Arm Type
Active Comparator
Arm Title
• Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/
Arm Type
Active Comparator
Arm Title
• Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Caudal dexamedatomidine analgesia
Intervention Description
Technique performance (Caudal block): classical technique; palpation, identification and puncture with the patients in the lateral position (permits easy access to the airway under general anesthesia) using a 22-G short-beveled needle under sterile conditions advancing needle pierces the sacrococcygeal ligament. After needle insertion, pre-calculated volume of Levob plus DEXM bolus was injected as follow; Group A Caudal Levob 0.125%+ DEXM 0.5µg/kg. Group B Caudal Levob 0.125%+ DEXM 1µg/kg. Group C Caudal Levob 0.125%+ DEXM 1. 5 µg/kg. Group D Caudal Levob 0.125%+ DEXM 2µg/kg.
Primary Outcome Measure Information:
Title
Time to (1st analgesic request objective pain score (OPS) ≥4)
Description
time from full recovery till child express moderate pain OPS 4 and ask for the first analgesic dose
Time Frame
Basal (0) till 24 hours.

10. Eligibility

Sex
Male
Gender Based
Yes
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 164 boys (age 1-8 years, ASA I) scheduled for hypospadias surgery Exclusion Criteria: Operative time exceeding 3 hours, bodyweight >25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
mohamed A Ghanem, A professor
Organizational Affiliation
Mansoura Univeristy
Official's Role
Study Chair
Facility Information:
Facility Name
Anesthesia department,Faculty of medicine, Mansoura univerisety
City
Mansoura
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Caudal Dexmedetomidine Analgesia in Pediatrics .

We'll reach out to this number within 24 hrs